CMS In Brief
This article was originally published in The Gray Sheet
Medicare updates: “Inherent reasonableness,” DRGs and more.
You may also be interested in...
The firm’s specialized endovascular abdominal aortic aneurysm product was the only device newly awarded a new-technology add-on payment for fiscal 2013, and was moved to a higher-paying procedure category than CMS had previously proposed.
The use of a relatively obscure CMS fee-adjustment authority rather than competitive bidding to lower Medicare payment for diabetes testing supplies in the retail setting could be precedent setting.
The latest product approvals and launches in cardiology, orthopedics, diagnostics and more.